These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14491056)

  • 1. [Study of the antilipemic and anticoagulant activity of a heparin derivative].
    REGAZZINI A; RODARI T
    Rass Fisiopatol Clin Ter; 1961 Apr; 33():301-16. PubMed ID: 14491056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antilipemic and non-anticoagulant decomposition product of heparin].
    ZOLLNER N; ROTHEMUND E; SEITZ W
    Klin Wochenschr; 1954 Dec; 32(45-46):1096-7. PubMed ID: 13234288
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental studies of the problem of the antilipemic eff. of heparin.
    INDERBITZIN T
    Schweiz Med Wochenschr; 1954 Oct; 84(40):1150-4. PubMed ID: 13225615
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral activity of an antilipemic heparide: N-monomethyl-3,5-dimethylbenzheparide amide].
    PLOTKA C; BUCOURT R; POTTIER J
    C R Hebd Seances Acad Sci; 1963 Jun; 256():5239-41. PubMed ID: 13944082
    [No Abstract]   [Full Text] [Related]  

  • 5. Antilipemic activities of several new heparinoids.
    HLADOVEC J; ROUBAL Z; MANSFELD V
    Experientia; 1957 May; 13(5):190-1. PubMed ID: 13447921
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilipaemic agent without anticoagulant action.
    BESTERMAN EM; EVANS J
    Br Med J; 1957 Feb; 1(5014):310-2. PubMed ID: 13396242
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anticholesteremic and antilipemic effects of a non-estrogenic hexoestrol derivative known as coronary dilator].
    ANNONI G; LONGARETTI A
    Med Welt; 1961 Sep; 38():1945-7. PubMed ID: 13861698
    [No Abstract]   [Full Text] [Related]  

  • 8. SUBLINGUAL HEPARIN; THE INABILITY TO DETECT LIPID-CLEARING OR ANTICOAGULANT EFFECTS OF HIGH DOSES.
    SPUDIS EV; HUTAFF LW; MILLER HS; LOFLAND H
    Neurology; 1965 May; 15():486-90. PubMed ID: 14288641
    [No Abstract]   [Full Text] [Related]  

  • 9. [On blood hypercoagulability following the anticoagulant effect of heparin].
    BOCCARDI V; DERIU L
    Prog Med (Napoli); 1961 Sep; 17():607-14. PubMed ID: 13870323
    [No Abstract]   [Full Text] [Related]  

  • 10. [On a biological test for antilipemic derivatives of heparin].
    HERBAIN M
    Clin Chim Acta; 1960 Mar; 5():204-7. PubMed ID: 14401197
    [No Abstract]   [Full Text] [Related]  

  • 11. [ANTILIPEMIC EFFECT OF ACID SODIUM HEPARIN AFTER SUBLINGUAL OR RECTAL ADMINISTRATION].
    SCHOELL H; KOPITZKI F
    Klin Wochenschr; 1964 Jul; 42():699-707. PubMed ID: 14250912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Research on a pyramidon derivative without delayed action on a simultaneously administered anticoagulant coumarin derivative].
    SCHULT A; GRUNDNER HG; HARTERT H
    Med Welt; 1962 Feb; 6():312-4. PubMed ID: 13909474
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heparin tolerance and blood coagulation factors in obliterating arteriopathy].
    WALCHER A; GOOSSENS N; HESS H; STUMPF W
    Klin Wochenschr; 1960 Sep; 38():952. PubMed ID: 13782625
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antilipemic effect of heparin. II. Changes of lipid concentration and lipase activity; problems of the reversibility of heparin action].
    GERO S; ROHNY B; GACS J
    Magy Belorv Arch (1955); 1958 Feb; 11(1):29-33. PubMed ID: 13551235
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antilipemic and hyperglycemic heparin effects in alloxan diabetes].
    LUSZTIG G; HORVATH E; KOSZEGI B; ORMOS J
    Z Gesamte Inn Med; 1955 Jun; 10(11):548-52. PubMed ID: 13257348
    [No Abstract]   [Full Text] [Related]  

  • 16. Antilipemic effect of heparin and phenindione.
    CHOUHAN BS; GUPTA NN
    Indian J Med Sci; 1963 Apr; 17():294-9. PubMed ID: 14021036
    [No Abstract]   [Full Text] [Related]  

  • 17. [The in-vitro heparin tolerance test in practice. II. The control of anticoagulant therapy].
    DALLA VOLTA S; FUSARO A
    Prog Med (Napoli); 1961 Apr; 17():223-30. PubMed ID: 13719441
    [No Abstract]   [Full Text] [Related]  

  • 18. Thrombelastographic studies with a twenty-four-hour schedule for subcutaneous heparin. A comparison of its efficiency with prothrombin-depressing agents.
    ELIOT RS; VON KAULLA KN; BLOUNT SG
    Circulation; 1961 Nov; 24():1206-14. PubMed ID: 13889849
    [No Abstract]   [Full Text] [Related]  

  • 19. Heparin resistance determined by the heparin tolerance test in patients treated with phenylindanedione before, during, and after operation.
    GORMSEN J; HAXHOLDT BF
    Acta Chir Scand; 1961; 121():367-76. PubMed ID: 13707283
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experimental cholesterin atherosclerosis in the rabbit: action of a duodenal heparinoid. III. Modifications in the factors of hemocoagulation, plasmin and plasminogen, and in the thromboplastin and fibrinolytic activity of the aortic wall].
    SOARDI F; NICROSINI F; DEL FAVERO A; PASOTTI C
    Farmaco Prat; 1961 Nov; 16():560-8. PubMed ID: 14039393
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.